栄研化学(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4549/E00961 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2021/11/19 | 日証協 | 145,345株 | +23.04% | 147,837株 | -4.26% | 251,760株 | +3.37% | 56,189株 | -59.34% |
2021/11/05 | 日証協 | 101,831株 | +13.77% | 86,845株 | -9.19% | 294,373株 | +23.67% | 77,857株 | -55% |
2021/10/29 | 日証協 | 89,506株 | +22.86% | 95,635株 | +99.22% | 238,038株 | +22.23% | 173,023株 | +55.49% |
2021/10/22 | 日証協 | 72,853株 | -2.54% | 48,004株 | +375.29% | 194,742株 | -15.93% | 111,279株 | +67.64% |
2021/10/15 | 日証協 | 74,749株 | -17.33% | 10,100株 | -81.46% | 231,641株 | -2.44% | 66,379株 | -1.5% |
2021/10/08 | 日証協 | 90,419株 | -26.97% | 54,471株 | +170.03% | 237,426株 | -13.56% | 67,388株 | -66.72% |
2021/10/01 | 日証協 | 123,808株 | -8.61% | 20,172株 | -70.99% | 274,661株 | +16.63% | 202,464株 | +55.26% |
2021/09/24 | 日証協 | 135,471株 | -20.3% | 69,523株 | -54.53% | 235,507株 | +0.36% | 130,400株 | +93.92% |
2021/09/17 | 日証協 | 169,966株 | +21.15% | 152,883株 | +181.03% | 234,672株 | -19.76% | 67,243株 | -43.36% |
2021/09/10 | 日証協 | 140,295株 | +136.62% | 54,400株 | +55.87% | 292,472株 | +34.85% | 118,717株 | +62.8% |
2021/09/03 | 日証協 | 59,291株 | -17.07% | 34,900株 | +1838.89% | 216,882株 | -0.28% | 72,920株 | +41.38% |
2021/08/27 | 日証協 | 71,491株 | +1.69% | 1,800株 | -82.41% | 217,483株 | -3.13% | 51,576株 | +16.42% |
2021/08/20 | 日証協 | 70,300株 | +0.72% | 10,233株 | -8.21% | 224,511株 | +5.7% | 44,300株 | +16.74% |
2021/08/13 | 日証協 | 69,800株 | -3.16% | 11,148株 | -42.24% | 212,411株 | -4.19% | 37,948株 | +37.99% |
2021/08/06 | 日証協 | 72,076株 | -19.92% | 19,300株 | -60.63% | 221,711株 | -23.07% | 27,501株 | -72.62% |
2021/07/30 | 日証協 | 90,000株 | -55.13% | 49,024株 | +273% | 288,210株 | -25.58% | 100,424株 | +184.26% |
2021/07/21 | 日証協 | 200,576株 | -1.87% | 13,143株 | -79.28% | 387,259株 | -3.73% | 35,328株 | -54.2% |
2021/07/16 | 日証協 | 204,391株 | -17.71% | 63,443株 | -53.03% | 402,274株 | -6.9% | 77,143株 | -52.97% |
2021/07/09 | 日証協 | 248,391株 | +4.07% | 135,071株 | +23.2% | 432,072株 | +19.77% | 164,018株 | +39.35% |
※株式分割は考慮していませんのでご注意ください。
Page Top